Close Menu

Applied Biosystems, Qiagen Ink PCR Licensing Deal

Applied Biosystems has granted a license to Qiagen under an expanded PCR license program that Applied Biosystems launched in June, the companies announced this week.

ABI's expanded program includes patents for real-time PCR and other PCR-related technologies not licensed under its previous PCR licensing program. Specifically, the program includes a license to foundational patents, the TaqMan assay, and the Dye-Intercalation assay method.

Financial terms of the arrangement were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.

The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.

Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.

In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.